The development of drugs that target angiogenesis and signal transduction pathways in the treatment of metastatic renal cell carcinoma (RCC) has led to improved survival rates for patients.
Barbara Fletcher
Articles by Barbara Fletcher
The treatment of advanced renal cell carcinoma (RCC) remains a major challenge for clinicians. However, according Daniel J. George, MD, the progress being made in understanding RCC tumor biology is already helping us to discover better, more effective treatments.
Latest Updated Articles
Treatment of Advanced Renal Cell CarcinomaOctober 25th 2013
Patient-Centered Management of Metastatic Renal Cell CarcinomaDecember 5th 2013